Atlas Trials

Everolimus and Capecitabine in Patients With Advanced Malignancy

Clinical trial NCT01079702 · UNKNOWN

Trial details

NCT number
NCT01079702
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Malignancies
Start date
2008-04-01
Primary completion
2010-04-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.